Navigation Links
New Hope for Tough-to-Treat Cancers
Date:5/31/2008

standard of care for adjuvant treatment of pancreatic patients."

"This represents a very substantial improvement in outcome for these individuals, and I think we can look forward to seeing widespread adoption of gemcitabine for patients with pancreatic cancer that can be surgically removed," Schilsky said.

Researchers at the ASCO meeting also reported progress with another tough-to-treat cancer, advanced kidney cancer.

While there have been significant advances in recent years with drugs such as Sutent (sunitinib), that success has brought a new challenge: How to treat patients who don't respond to the latest generation of new therapies.

Enter everolimus, a drug which interferes with blood supply to the tumor and which is one of the first in a relatively new class of compounds. Patients randomized to receive everolimus plus best existing therapy had a 70 percent reduction in the risk of recurrence or death, compared to patients who received best existing therapy alone. For patients on everolimus, it took about four months for the cancer to return, versus about two months in the placebo group.

"While that may not sound like an enormous leap forward, it's actually a very important observation for several reasons," Schilsky explained. "This drug is targeting a different molecular pathway compared to anti-angiogenesis drugs [those that block blood supply to the tumor], so it's working in a completely different way. Secondly, when we make these observations, not only do patients benefit from a delay in progression of their cancer, but this kind of observation always gives us a new lead and an interest in moving these drugs up earlier into cancer treatment."

"A setting of unmet clinical need that has now been filled," added study author Dr. Robert Motzer, an attending physician at Memorial Sloan-Kettering Cancer Center in New York City. "Everolimus should be the standard of care in this setting, pending approv
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. New Drug Promising Against Tough-to-Treat Kidney Cancer
2. NEW DATA FOR PAZOPANIB - GSKS LATEST INVESTIGATIONAL ANTI-CANCER AGENT - SHOWS PROMISE ACROSS MULTIPLE CANCERS
3. Laser Therapy a New Option for Vocal-Cord Cancers
4. Data re-analysis shows drug finasteride reduces risk for most prostate cancers
5. Radiation for Prostate Cancer Raises Risk of Other Cancers
6. Kidney Cancers More Likely to Be Diagnosed Early
7. Majority of kidney cancers diagnosed at earliest stage
8. High-Tech Imaging No Better for Diagnosing Head/Neck Cancers
9. Coupled With Mammography, Ultrasound Finds More Breast Cancers
10. New Treatment Offers Hope for Beating Aggressive Cancers
11. Potential viral therapy weapon for difficult cancers is safe and effective in study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... , ... August 28, 2015 , ... ... patient loyalty at a low cost. Personalized with practice contact information and logos, ... patients. Dental offices can also incorporate Calendars into seasonal mailings, thank you and ...
(Date:8/28/2015)... , ... August 28, 2015 , ... ... announce its collaboration with coffee connoisseur and Emmy-nominated actress, Sofia Vergara, and unveil ... features revolutionary Thermal Flavor Extraction™ technology, which delivers a variety of sizes and ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Medicare-Medicaid Dual Eligibles Database have added comprehensive information on two new duals ... for a December 2015 launch; and Idaho’s partnership to revamp Blue Cross ...
(Date:8/28/2015)... ... August 28, 2015 , ... The Plaintiffs ... as MDL 2545, Testosterone Replacement Therapy Products Liability Litigation, are in the midst ... custodial files the PSC may receive for corporate employees involved in the production ...
(Date:8/28/2015)... ... ... launched their new website this summer. The new user-friendly site has a ... design. Website users will now have an improved browsing experience on their phones, tablets, ... the monthly turf-tips email, and find a local Super-Sod store all from the convenience ...
Breaking Medicine News(10 mins):Health News:SmartPractice® Introduces 2016 Calendars for Dental Practice Giveaways 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 2Health News:Sofia Vergara Partners With SharkNinja® To Launch The Ninja Coffee Bar™ 3Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 2Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 3Health News:National Testosterone Lawyers Provide Testosterone Lawsuit MDL Update 4
... Oct. 31 /Xinhua-PRNewswire-FirstCall/ -- Genesis,Pharmaceuticals Enterprises, Inc. ... a U.S. pharmaceutical company with its principal ... granted leave by the American,Arbitration Association ("AAA") ... defamation and breach of contract in a ...
... to be anti-inflammatory in several animal injury models. Recent ... and liver against lethal doses of endotoxin in rat ... transplantation. The influence of dietary glycine on oxidant-induced or ... article to be published on October 21, 2008 in ...
... International Osteoporosis Foundation (IOF) has backed the National Osteoporosis ... on the prevention and treatment of osteoporosis. ... National Societies said "we support any initiative that is ... in this instance we do not believe this is ...
... latest advances in,autism research, treatment and therapy will ... Lauderdale. The comprehensive four-day,conference, hosted by the National ... for November 13 through 16 at the Hyatt ... The conference will feature keynote speaker U.S. ...
... Wolters Kluwer, a,market leading global information services and ... of Robert Becker to the,position of President and ... Becker is currently CEO of Wolters Kluwer Law ... CEO of Wolters Kluwer Law &,Business (U.S.)., ...
... 31 SCOLR Pharma, Inc.,(Amex: DDD ) today ... Friday, November 7, 2008, at 8:30 a.m. Eastern. Daniel ... the conference call at 11:30,a.m. Eastern, to discuss the ... interested parties may participate in the,conference call by dialing ...
Cached Medicine News:Health News:Genesis Pharmaceuticals Files Counter Claims 2Health News:National Autism Conference to be Held in Weston, FL November 13-16 2Health News:Wolters Kluwer Appoints Robert Becker as President and CEO Wolters Kluwer Health; and Stacey Caywood as President and CEO Wolters Kluwer Law & Business (U.S.) 2Health News:Wolters Kluwer Appoints Robert Becker as President and CEO Wolters Kluwer Health; and Stacey Caywood as President and CEO Wolters Kluwer Law & Business (U.S.) 3Health News:Wolters Kluwer Appoints Robert Becker as President and CEO Wolters Kluwer Health; and Stacey Caywood as President and CEO Wolters Kluwer Law & Business (U.S.) 4Health News:SCOLR Pharma, Inc. Schedules Third Quarter 2008 Financial Results Conference Call for November 7, 2008 at 11:30 A.M. Eastern 2
(Date:8/28/2015)... ANGELES , FARUM, Denmark and ... On July 31, 2015 the US Food and ... the treatment of Major Depressive Disorder in adult patients who ... in the current episode. TMS is a non-invasive technique for ... in patients suffering from Major Depressive Disorder. The procedure has ...
(Date:8/28/2015)... ANDOVER, Massachusetts and LONDON , ... driven approach seamlessly ... health continuum improving outcomes and ... Philips  (NYSE: PHG AEX: PHIA) today announced its presence ... its latest cardiology solutions, including Heart Model A.I. , EchoNavigator ...
(Date:8/27/2015)... -- Biosimilars are not generics and the Biologics ... Drug Administration (FDA) for recognizing that each biosimilar ... issued today. The FDA,s draft guidance on nonproprietary ... for biological products to bear a nonproprietary name ... the agency,s thinking that "there is a need ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... 15, 2012  Fluke Biomedical announced today the newest ... quality-assurance testing and troubleshooting tools, the SPOT ... 15-second preventive maintenance (PM) test for SpO2 patient ... the fastest SpO2 functional tester ever achieved by ...
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today announced ... other conditions, shares of its common stock in an underwritten public ... the offering may be completed, or as to the actual size ... and Piper Jaffray & Co. are acting as joint book-running managers ...
Cached Medicine Technology:Fluke Biomedical launches speedy new ProSim™ SPOT Light SpO2 Functional Tester 2Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock 3Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock 4
The ultra micro tip for the new Eppendorf 2000/2100 series ultra micro pipettors provides accurate drawing and dispensing everytime....
Ambion's barrier tips prevent cross-contamination of samples by means of an aerosol filter. They are RNase- and DNase-free and are ideal for handling RNA, PCR applications, and for working with radio...
... as both regular and filter tips. Sterilized ... more efficient sterilization and are delivered with ... of irradiation. Sterilized Diamond Tips are ready ... Diamond Tips are wrapped in medical device ...
This long 10 L tip features a MicroPoint design for the original Finnpipette 0.5-10 L and the new Finnpipette 0.5-10 L universal fit pipettors....
Medicine Products: